|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:331-339
© 2000 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From the Department of Pediatric Cardiothoracic Surgery, Childrens Hospital of Pittsburgh, Pittsburgh, Pa.
Address for reprints: Frank A. Pigula, MD, Department of Pediatric Cardiothoracic Surgery, Room 2820, 2 Main, Childrens Hospital of Pittsburgh, Pittsburgh, PA 15213 (E-mail: Pigulaf{at}heart.chp.edu)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Because of these concerns, we have developed a technique of regional perfusion during neonatal aortic arch reconstruction.
8 Guided by near-infrared spectroscopy (NIRS), this technique drastically reduces circulatory arrest time and maintains cerebral blood volume and oxygen saturation while providing the same surgical exposure obtained during DHCA. We report our experience using this technique in 6 neonates who underwent extensive aortic arch reconstructions.
| Methods |
|---|
|
|
|---|
|
|
Anesthetic and perfusion management.
Anesthetic and cardiopulmonary bypass management was standardized and was the same for both groups of patients. Anesthetic technique was consistent and used high-dose opiates for all patients. During cooling, cardiopulmonary bypass flow was maintained between 2.0 and 2.5 L · min1 · m2 to achieve a rectal temperature of 18°C. Blood gas management was by the alpha-stat technique.
Monitoring.
Standard hemodynamic monitoring was applied to all children. Arterial blood pressure was monitored by a left radial artery catheter. Rectal and esophageal temperature probes were inserted for temperature management. After informed consent was obtained, all children underwent intraoperative monitoring of relative cerebral blood volume index (CrBVI) and oxygen saturation (CrSO2) with NIRS (INVOS 4100; Somanetics Corp, Troy, Mich; NIRO 500; Hamamatsu Phototomics, Hamamatsu, Japan). A sensor placed on the right lateral forehead monitored CrSO2 and CrBVI. Relative CrBVI and percent oxyhemoglobin saturation were displayed in real time, and these data were used to direct the rate of RLFP. Data were downloaded and stored for later analysis.
Data acquisition.
Standard hemodynamic monitoring was applied to all patients. Patients who underwent DHCA without RLFP served as control subjects, and CrBVI and CrSO2 were compared with those of neonates who underwent aortic arch reconstruction with RLFP. Arterial blood pressure was obtained through a left radial arterial line. After the induction of anesthesia and before the draping of the patient, NIRS sensors were placed over the right frontoparietal area of the brain. Data were sampled every 2 seconds and saved to disk. Data acquisition began with sensor placement and ended with patient transport to the intensive care unit. Baseline CrBVI and CrSO2 were obtained after the institution of full cardiopulmonary bypass support and after core cooling but before circulatory arrest or RLFP. Data in Table II are presented as change in CrBVI (
CrBVI) and CrSO2 (
CrSO2) during RLFP or circulatory arrest as compared with baseline values. Percent return to baseline was measured when both relative CrBVI and CrSO2 stabilized on RLFP.
|
| Results |
|---|
|
|
|---|
CrBVI) and CrSO2 (
CrSO2) as compared with patients whose condition was supported with RLFP (Table IIBecause of concerns about cerebral hyperperfusion, we used real-time NIRS data to gradually increase the rate of RLFP until CrBVI was restored to baseline levels (obtained on full cardiopulmonary support). Restoration of baseline CrBVI consistently occurred with a RLFP rate of 20 mL · kg1 · min1. Furthermore, with the restoration of CrBVI, CrSO2 was also restored to baseline values (Fig 2). This is in contrast to children in the control group who experienced a prompt and predictable decline in both CrBVI and CrSO2 (Figs 3 and 4).
|
|
|
| Discussion |
|---|
|
|
|---|
Thus although DHCA may be a valuable technique, efforts to limit the duration of DHCA are necessary. Although the safe duration of DHCA is unclear, most clinical and experimental evidence suggests that hypothermia (16°C-18°C) provides adequate neuroprotection for 30 to 45 minutes.
1,12,13 Although this duration may appear to be well tolerated, the studies that are cited reinforce a compelling intuitive desire to reduce DHCA time to an absolute minimum. Reports exploring the minimum circulatory requirements of the brain supported by cardiopulmonary bypass suggest that low flow is better than no flow; common sense dictates that less circulatory arrest time is better than more.
11,14
With this in mind, alternatives to DHCA have been sought. Asou and colleagues
15 and Sano and colleagues
16 have described a similar technique but provided no data to support the contention that the brain was sustained. McElhinney and colleagues
17 described technical modifications that minimize DHCA duration in infants undergoing the Damus-Kaye-Stansel procedure. This recent interest in alternatives to DHCA underscores a growing awareness that neurologic injury is a serious concern during heart surgery in neonates and infants. Although much time and effort have been directed toward developing strategies to minimize the neurologic injury associated with DHCA, we suggest the simplest and most direct strategy is to minimize exposure to the insult as much as possible.
RLFP accomplishes this goal by providing cerebral circulatory support and greatly reducing the duration of DHCA required for neonatal arch reconstruction. This already brief (average, 9 minutes) duration may be reduced even further by the initiation of cardiopulmonary bypass through the shunt. We have no experience with this modification but are concerned about the potential for cerebral hyperperfusion and somatic hypoperfusion in the presence of a diminutive aorta, particularly at normothermia.
NIRS is a recent, noninvasive technology capable of measuring changes in tissue chromophores, such as hemoglobin.
18 NIRS exploits the differences in absorption peaks between oxygenated and deoxygenated hemoglobin and provides information on the changes, or relative differences, in these compounds over time.
19 Again, these are relative changes; absolute values require the measurement of the path length of the NIRS signal, which is not readily available with current technology. The relative CrBVI and CrSO2 are mainly determined by the cerebral venous blood because it comprises about 75% of intracranial blood volume (arterial, approximately 20%; capillaries, approximately 5%).
20 However, there is a strong clinical correlation between the NIRS signal and flow in the internal carotid artery, and NIRS has been used in neonatologic procedures and in pediatric heart surgery.
21-23
The use of NIRS technology has guided our RLFP rate and enabled us to document that regional perfusion of the brain provides the same CrBVI and CrSO2 that are provided by standard cardiopulmonary bypass support. Although data defining the lower limit of blood flow to the human neonatal brain are not available, our finding that 20 mL · kg1 · min1 RLFP is required for CrBVI and CrSO2 restitution is consistent with animal studies. Using a dog model, Miyamoto and colleagues
24 concluded that the optimal perfusion rate for the brain at 20°C was 30 mL · kg1 · min1, with oxygen debt and anaerobic metabolism when flow rate was less than 15 mL · kg1 · min1. In sheep, Swain and colleagues
25 showed preservation of energy substrates with flows as low as 10 mL · kg1 · min1. Because of concerns about cerebral hyperperfusion with the use of RLFP, we believed it appropriate to limit the perfusion rate such that baseline CrBVIs (measured by NIRS on full-flow hypothermic cardiopulmonary bypass) were maintained. In this way NIRS allows us, for the first time, to quantify blood flow requirements of the neonatal brain at hypothermic temperatures. Thus for the human neonate, the data suggest that 20 mL · kg1 · min1 (delivered with this technique and using alpha-stat blood gas management) provides adequate cerebral circulatory support.
This is an important qualification because we did not quantify the flow distribution (ie, right subclavian vs right common carotid arteries) during RLFP. Flow distribution will depend on the relative resistances in the perfused vascular beds. Although it has been shown that cerebral vascular resistance increases with hypothermia, systemic vascular resistance can be expected to increase even more.
26 Thus we believe that most of the RLFP preferentially enters the cerebral circulation and that intracranial and extracranial arterial collateral connections between the head the left radial artery are required to explain a left radial arterial pressure of 22 mm Hg. Furthermore, our observation of substantial back bleeding from the descending thoracic aorta leads us to speculate that RLFP provides some degree of somatic circulatory support in addition to cerebral support. This finding presumably results from an extensive network of arterial collaterals between the upper body and the descending aorta in the neonate. This degree of collateralization is apparent clinically by the low incidence of paraplegia encountered in neonatal coarctation repair.
27 These collaterals would include not only intracranial connections through the circle of Willis but also extracranial arteries, vertebral arteries, internal thoracic arteries, and intercostal arteries. Somatic perfusion through these collaterals may serve to attenuate the metabolic burden of DHCA, placing neonates in a better physiologic position to tolerate the postoperative period. Although RLFP under DHCA may increase edema formation, we have not identified this as a clinical problem. Indeed, despite a low threshold for leaving the sternum open after a stage I Norwood operation, this was required in only 1 of 4 patients who were palliated for HLHS. These findings deserve further investigation because circulatory support of the subdiaphragmatic viscera may impart a significant survival advantage.
Although extensive neonatal aortic arch reconstruction may be required in a variety of conditions, it is most commonly performed in stage I Norwood operation for HLHS.
28,29 It is in this group of patients that important secondary benefits of RLFP should be recognized. By supporting the brain during construction of the neoaorta, the time allowed for the performance of a technically precise reconstruction is extended. This is a critically important point because the success of the Norwood operation hinges on the achievement of 3 surgical goals:
The importance of achieving these goals has been illustrated by Bertram and colleagues,
30 who reviewed the autopsy results in 122 patients who died after a Norwood operation. They found that 27% of the deaths were from impaired coronary perfusion, 14% of the deaths were from neoaortic obstruction, 7% of the deaths were from bleeding, and 36% of the deaths were from inappropriate (excessive or inadequate) pulmonary blood flow. Allowing more time for the meticulous construction of the neoaorta, without the pressing need to limit circulatory arrest time, should make these goals more attainable.
As with HLHS, neonates who undergo complex aortic surgery resulting in biventricular repair may also be expected to benefit. This was in fact the case for patient 1 (Table I
), who was born with aortic valve atresia, aortic hypoplasia, and a large ventricular septal defect with a satisfactory left ventricle. This child underwent a Norwood-type reconstruction of the aorta, baffling of the ventricular septal defect to the neoaorta, and homograft reconstruction from the right ventricle to the pulmonary arteries. Thus RLFP may extend the surgeons capabilities when dealing with a variety of aortic pathologic conditions.
In summary, RLFP represents a new bypass management technique that significantly reduces the exposure of the neonatal brain to circulatory arrest during aortic arch reconstruction. This technique is simple and, based on the NIRS data, provides cerebral circulatory support equivalent to that provided by full-flow cardiopulmonary bypass. Furthermore, initial observations suggest that RLFP may provide some degree of somatic circulatory support as well. The reduction of DHCA time required for neonatal aortic arch reconstruction can be expected to reduce the risk of cognitive and psychomotor deficits and may reduce perioperative deaths.
| Appendix: Discussion |
|---|
|
|
|---|
There are two reasons why the manuscript is important. First, it addresses an evolving and controversial topic in congenital heart disease: Should DHCA continue to be used in repair of congenital heart disease? Some historical perspective is important here. Thirty years ago the pioneer surgeons who were developing cardiac surgery for neonates and infants used DHCA as a necessary and unavoidable adjunct to complex procedures in small infants. At that time, equipment, microsurgical technique, and experience did not allow any alternatives. As an aside, to emphasize this point we can look at the arterial switch operation. It is clear that the concept of that operation had been known for decades, but it was not until 1980 that a successful arterial switch was performed for transposition in neonates. The limitation was technical. Similarly, technical limitations in past decades regained the use of DHCA to achieve success in small infants. DHCA as a result was taught by the masters to the subsequent generation of pediatric heart surgeons, many of whom have simply accepted the fact that this practice was a necessary component of neonatal and infant repair. Even though the risks related to DHCA have been well documented, many surgeons consider this technique to be mandatory or at least preferred, especially in arch repair. This may have been true 30 years ago, but no longer is this technique necessary to repair even the most complex arch reconstructions.
The brain has evolved with its profound complexity over millions of years. It seems that it is a somewhat misplaced effort to spend millions in research money, not to mention the intellectual effort, in figuring out ways to reverse the profound physiologic and biochemical derangements induced by purposeful brain ischemia. Free radical spin traps and excitatory amino acid inhibitors are really only the tip of the iceberg in solving this very complex problem.
Why create a very complex problem using DHCA and then be faced with the profound additional problem of figuring out a way of solving it, when the problem itself can be completely avoided by eliminating the brain ischemia completely? It would seem that if a fraction of the money and research effort that have been put into studying ways to outsmart brain ischemia were put into developing relatively simple plumbing techniques of providing reliable continuous cerebral blood flow, we would solve this problem in a fraction of the time. DHCA is not necessary in modern practice, and it becomes clear that the research effort in brain ischemia, at least as it pertains to the practice of cardiac surgery, has been misplaced if we accept this fact. The current emphasis on outsmarting brain ischemia only makes sense if DHCA is absolutely necessary, and as you have shown in this study, it is not.
Old comfortable habits die hard. DHCA is comfortable and easy for many surgeons. This manuscript, therefore, represents an important addition to the growing number of groups moving away from DHCA, and you should be congratulated for this effort.
The second reason why this manuscript is important is that it is the first study that actually attempts to quantify cerebral blood flow and cerebral metabolism using continuous regional perfusion techniques. These data are badly needed to document the efficacy of the technique and to stimulate appropriate modifications of the technique as we move ahead.
I have three questions for you. First, your method of cannulating the pulmonary artery first and then switching to the polytetrafluoroethylene graft seems somewhat redundant. Why dont you simply put the graft on first, cannulate it, and perfuse continuously? You would not have to perform even a brief period of circulatory arrest.
Dr Pigula. Thank you for your comments. The reason we have done that is to simplify the technique. As you rightly pointed out, Asou and his associates did describe a technique similar to this. Although they did not provide any saturation data, they did provide some pressure data. In their technique they used two separate cannulations. For the sake of expediency and simplicity, we use one cannula and simply move it, accepting a brief period of circulatory arrest.
Dr Hanley. At least in patients undergoing the Norwood procedure, the arches rarely are truly interrupted, and I can say our technique is to directly cannulate into the head vessels with a very small arterial cannula, either the base of the innominate or the carotid artery, and perfuse that way right from the very beginning. We get excellent cooling using multiple temperature probes placed on different regions of the body. It is just another way to do it.
The second question relates to your method of documenting blood flow and metabolism. I, and possibly others, am not particularly familiar with the method and limitations of cerebral NIRS. Does it matter that you put the sensor lateralized to one side of the brain? Detractors of this technique may say that if you are perfusing the right side and you have your sensor on the right side, despite flow through the circle of Willis, the left side of the brain may be in danger. Does this method globally average the entire brain or is it biased to the side on which you put the sensor? Should you put the sensor on the other side? Should you be using tympanic membrane probes in both ears to see if there are shifts in temperature to obtain quantitative regional data?
Dr Pigula. That is a very good point. What we are measuring is a regional reflection of cerebral saturations and blood volume. Therefore, the answer is, yes, we should at least investigate what the results would be, for instance, on the left frontoparietal area. I suspect they are going to be the same, but I have not proven that.
Dr Hanley. Are you considering doing this in other arch problems that have two ventricles, such as interrupted aortic arch and other complex arch reconstructions?
Dr Pigula. Yes. Actually one of the patients in this report underwent biventricular repair. One of those patients was a neonate with aortic atresia and a hypoplastic arch just like a typical patient with HLHS; however, that baby had a left ventricle with a ventricular septal defect, and we did use this technique to do a biventricular repair at 8 days of age. I think it is justified under those circumstances in the face of a very complex aortic arch reconstruction necessitating a long period of DHCA.
Dr Christo Tchervenkov (Montreal, Quebec, Canada). As someone who also does quite a bit of neonatal aortic arch reconstruction, particularly in complex two-ventricle hearts, I endorse this trend away from DHCA. However, at the Montreal Childrens Hospital we have gone in that direction a lot more cautiously than Dr Hanleys group has, for a number of reasons. DHCA was important historically in allowing pioneer surgeons to finally accomplish neonatal repairs and improve the survival of these patients. I believe that one of the most important determinants for survival and also for brain protection is the achievement of a complete and accurate anatomic repair. Therefore embracing surgical techniques that avoid circulatory arrest must not be done at all costs if they compromise the accuracy of the intracardiac repair or if those techniques might result in anatomic stenoses of the cerebral vessels.
In patients other than those with HLHS, we have placed the aortic cannula in the ascending aorta at the base of the innominate artery. At the time of doing the aortic arch repair, we advance the cannula without taking it out into the innominate artery for regional perfusion, while the aortic arch is repaired, and then pull it back into the ascending aorta for the rest of the operation, again without taking it out. Do you have any experience with the technique I just described in lesions other than HLHS?
Dr Pigula. No, sir, I do not.
Dr Tchervenkov. We have to be very cautious about direct cannulation of the innominate artery because of the possibility of causing significant stenosis in these small vessels in very small babies. While we embrace this trend, we also have to spend the time, as Dr Hanley suggested, to develop new cannulas and new techniques so that eventually we can safely avoid circulatory arrest in all patients.
Your technique involves transfer of the aortic cannula from the pulmonary artery to the shunt. This introduces the possibility of air embolization to the brain. Can you describe more precisely how you avoid air into the shunt, because you have to stop the circulation to transfer the cannula?
Dr Pigula. It is just another technical feature. A 3.5-mm polytetrafluoroethylene shunt will accept an 8F or 10F Bio-Medicus cannula. We carefully deair it by deairing the cannula and the shunt. Then, before opening the shunt, we just temporarily occlude the right common carotid artery, so even if there is any residual air left in the circuit, it will be directed down the right subclavian artery rather than to the brain.
To address your other concerns, which I share, I would argue that the longer and the more complex the aortic construction and the longer the potential for circulatory arrest, the better off you are with some form of support. With continued support you do not have the time constraints that you may have during circulatory arrest conditions, and your technical outcome may be better for that reason.
| Footnotes |
|---|
*Gore-Tex conduit, regisyered trademark of W. L. Gore & Associates, Inc, Flagstaff, Ariz.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Farouk, M. Karimi, M. Henderson, J. Ostrowsky, E. Siwik, and H. Hennein Cerebral regional oxygenation during aortic coarctation repair in pediatric population. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 26 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Fricker Hypoplastic Left Heart Syndrome: Diagnosis and Early Management NeoReviews, June 1, 2008; 9(6): e253 - e259. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meybohm, G. Hoffmann, J. Renner, A. Boening, E. Cavus, M. Steinfath, J. Scholz, and B. Bein Measurement of Blood Flow Index During Antegrade Selective Cerebral Perfusion with Near-Infrared Spectroscopy in Newborn Piglets Anesth. Analg., March 1, 2008; 106(3): 795 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kanter, W. T. Mahle, B. E. Kogon, and P. M. Kirshbom What is the Optimal Management of Infants With Coarctation and Ventricular Septal Defect? Ann. Thorac. Surg., August 1, 2007; 84(2): 612 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Goldberg, E. L. Bove, E. J. Devaney, E. Mollen, E. Schwartz, S. Tindall, C. Nowak, J. Charpie, M. B. Brown, T. J. Kulik, et al. A randomized clinical trial of regional cerebral perfusion versus deep hypothermic circulatory arrest: Outcomes for infants with functional single ventricle J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 880 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, J. Bennetts, S. Verma, and C. A. Caldarone New Developments in the Treatment of Hypoplastic Left Heart Syndrome Pediatrics, January 1, 2007; 119(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Oppido, C. P. Napoleone, S. Turci, B. Davies, G. Frascaroli, S. Martin-Suarez, A. Giardini, and G. Gargiulo Moderately Hypothermic Cardiopulmonary Bypass and Low-Flow Antegrade Selective Cerebral Perfusion for Neonatal Aortic Arch Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2233 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Amir, C. Ramamoorthy, R. K. Riemer, C. R. Davis, F. L. Hanley, and V. M. Reddy Visual light spectroscopy reflects flow-related changes in brain oxygenation during regional low-flow perfusion and deep hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1307 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hannan, M. A. Ybarra, J. W. Ojito, F. A. Alonso, A. F. Rossi, and R. P. Burke Complex Neonatal Single Ventricle Palliation Using Antegrade Cerebral Perfusion. Ann. Thorac. Surg., October 1, 2006; 82(4): 1278 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
Antegrade cerebral perfusion reduces apoptotic neuronal injury in a neonatal piglet model of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 659 - 665. |
||||
![]() |
C. L. Dent, J. P. Spaeth, B. V. Jones, S. M. Schwartz, T. A. Glauser, B. Hallinan, J. M. Pearl, P. R. Khoury, and C. D. Kurth Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 190 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Dent, J. P. Spaeth, B. V. Jones, S. M. Schwartz, T. A. Glauser, B. Hallinan, J. M. Pearl, P. R. Khoury, and C. D. Kurth Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tlaskal, B. Hucin, V. Kucera, P. Vojtovic, R. Gebauer, V. Chaloupecky, and J. Skovranek Repair of persistent truncus arteriosus with interrupted aortic arch Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Amir, C. Ramamoorthy, R. K. Riemer, V. M. Reddy, and F. L. Hanley Neonatal Brain Protection and Deep Hypothermic Circulatory Arrest: Pathophysiology of Ischemic Neuronal Injury and Protective Strategies Ann. Thorac. Surg., November 1, 2005; 80(5): 1955 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Skinner, L. A. Halstead, C. S. Rubinstein, A. M. Atz, D. Andrews, and S. M. Bradley Laryngopharyngeal dysfunction after the Norwood procedure J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1293 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Fesseha, B. W. Eidem, D. J. Dibardino, S. G. Cron, E. D. McKenzie, C. D. Fraser Jr, J. F. Price, A. C. Chang, and A. R. Mott Neonates With Aortic Coarctation and Cardiogenic Shock: Presentation and Outcomes Ann. Thorac. Surg., May 1, 2005; 79(5): 1650 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Bichell, J. J. Lamberti, G. J. Pelletier, C. Hoecker, M. W. Cocalis, F. F. Ing, and R. A. Jensen Late Left Pulmonary Artery Stenosis After the Norwood Procedure is Prevented by a Modification in Shunt Construction Ann. Thorac. Surg., May 1, 2005; 79(5): 1656 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. De Oliveira, D. A. Ashburn, F. Khalid, H. M. Burkhart, I. T. Adatia, H. M. Holtby, W. G. Williams, and G. S. Van Arsdell Prevention of Early Sudden Circulatory Collapse After the Norwood Operation Circulation, September 14, 2004; 110(11_suppl_1): II-133 - II-138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. DiBardino, J. S. Heinle, G. C. Kung, G. T. Leonard Jr, E. D. McKenzie, J. T. Su, and C. D. Fraser Jr Anatomic reconstruction for recurrent aortic obstruction in infants and children Ann. Thorac. Surg., September 1, 2004; 78(3): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Ungerleider and J. W. Gaynor The Boston Circulatory Arrest Study: An analysis J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1256 - 1261. [Full Text] [PDF] |
||||
![]() |
D. B. Andropoulos, L. K. Diaz, C. D. Fraser Jr., E. D. McKenzie, and S. A. Stayer Is Bilateral Monitoring of Cerebral Oxygen Saturation Necessary During Neonatal Aortic Arch Reconstruction? Anesth. Analg., May 1, 2004; 98(5): 1267 - 1272. [Abstract] [Full Text] [PDF] |
||||